Marijuana Stocks & Public Companies

Canada’s Maricann looks to sell medical marijuana in German pharmacies

Ontario-based Maricann expects to start shipping dry cannabis flower to Germany in early 2018, making it the latest Canadian company to export medical marijuana to what could soon become the world’s largest MMJ market. The company’s German subsidiary, Maricann GmbH, also applied for a license to import Maricann’s cannabis from Canada with the intention of distributing […]

Read More

Aurora Cannabis goes on ambitious buying spree

Cash-rich Aurora Cannabis is steamrolling ahead with its aggressive domestic and international expansion plans, snapping up a leading international greenhouse design company and a late-stage marijuana production applicant in Quebec. Those deals came days after Aurora commenced a hostile takeover attempt of rival producer CanniMed Therapeutics in what could be the largest takeover in the industry […]

Read More

Canadian cannabis company to pay $1.6M for California dispensary

A Canadian marijuana company has entered into an agreement to buy a privately owned medical cannabis dispensary in California for $1.6 million (CA$2 million), the latest sign that interest in American MJ assets is slowly picking up in Canada. British Columbia-based Marapharm put down a cash deposit of $160,000 for Green Leaf Wellness in Desert Hot […]

Read More

New rules would have major impact on most Canadian cannabis businesses

A new set of regulatory proposals has been released by Health Canada that would have wide-ranging implications for most businesses in Canada’s marijuana industry — and even many stuck in the gray market. The regulations would facilitate the coming into force of the Cannabis Act – which is still subject to parliamentary approval – and […]

Read More

TerrAscend announces CA$52 million financing, Canopy partnership

A Mississauga, Ontario-based medical marijuana company is taking steps to raise 50 million Canadian dollars ($40 million) through a private placement of its securities to expand its existing facility and pursue strategic pharmaceutical assets. TerrAscend – traded on the Canadian Securities Exchange under the symbol TER – said in a news release that it entered […]

Read More

Ex-MassRoots CEO makes move to oust board, current leadership

MassRoots founder and former CEO Isaac Dietrich on Monday filed paperwork with federal regulators to call for a special meeting and new shareholder vote, an attempt to force his way back into the company and dethrone the other board members who fired him last month. Dietrich – who owns 15.82% of the company’s outstanding stock […]

Read More

Aurora to raise additional CA$100M for domestic, global growth

Aurora Cannabis has arranged a private placement of its securities to raise another 100 million Canadian dollars ($80 million), giving the Alberta producer a cash cushion totaling more than CA$340 million. The deal comes just two days after Aurora offered to acquire rival producer CanniMed Therapeutics for CA$544 million ($425 million) in stock. It’s unclear […]

Read More

Canadian companies aim to create medical cannabis powerhouse in Latin America

Canadian companies hope to cultivate a medical marijuana juggernaut in Colombia by combining Toronto’s capital and technological expertise with the Latin American nation’s favorable climate and location. Industry executives said they plan to use Colombia as a springboard to serve Latin America’s 400-plus million people who live in nations where some form of marijuana is […]

Read More

Aurora offers nearly CA$550M for rival as CanniMed seeks Newstrike

Merger mania is sweeping through Canada’s medical marijuana industry. Aurora Cannabis offered to acquire rival producer CanniMed Therapeutics for 544 million Canadian dollars ($425 million) in stock, a deal that would be the largest acquisition to date in the North American marijuana industry. If completed, the merger would create a global marijuana leader and could spark […]

Read More

MassRoots’ net loss widens, but cash reserves grow

MassRoots saw its red ink double in the third quarter, though the cannabis-focused social media network’s cash reserves were substantially higher than the previous three-month period. According to the company’s latest quarterly filing with the Securities and Exchange Commission, MassRoots posted a $7.1 million net loss in the third quarter versus $3.5 million a year earlier. Revenue […]

Read More

Cronos Group raises CA$17 million to fund R&D, boost marijuana production

Cronos Group has closed a stock deal that raised 17.2 million Canadian dollars ($13.5 million) to fund research and development, expand Canadian cannabis production capacity and develop distribution infrastructure. The deal brings to CA$90 the amount of capital the company has raised so far this year, including CA$40 million in debt, President and CEO Mike Gorenstein […]

Read More